论文部分内容阅读
美国Fox Chase癌中心R.L.Comis教授,在“走向2000年癌症研究与治疗学术讨论会”上指出,近年来已有不少种效果不错的化学药物,用于治疗和预防非小细胞肺癌。然而,除少数例外,本病争取治愈的手段,仍以外科手术为主。术前对于手术的可行性以及切除的可能性等,都必须作充分考虑。为此他列举了10项不宜手术的指标: ①病人年逾80岁,且有功能Ⅲ级的心脏病。②肺功能不良(1秒钟用力呼气量“PEV”
Prof. R.L. Comis of the Fox Chase Cancer Center in the United States pointed out at the “Towards the 2000 Cancer Research and Treatment Symposium” that in recent years there have been many good chemical drugs for the treatment and prevention of non-small cell lung cancer. However, with a few exceptions, the means to fight for this disease is still based on surgery. The feasibility of surgery and the possibility of resection before surgery must be fully considered. To this end, he listed 10 inoperable indicators: 1 The patient is over 80 years old and has a functional class III heart disease. 2 Poor lung function (1 second forced expiratory volume “PEV”